Of note, in both studies, a trend towards improved survival was observed in mice with SAMHD1‐deficient AML cells when comparing combination treatment with ara‐C treatment alone (P = 0.0737 and P = 0.0893). Here, SAMHD1 is linked to acute myeloid leukemia.